32 results
ARS
2023 FY
XFOR
X4 Pharmaceuticals Inc
29 Apr 24
Annual report to shareholders
4:58pm
JURISDICTIONS THAT PREVENT INSPECTIONS 80 PART III Item 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE 81 Item 11. EXECUTIVE COMPENSATION 81 Item 12 … . DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE The information required by this Item is incorporated by reference to the information set forth
S-8
EX-99.2
XFOR
X4 Pharmaceuticals Inc
11 Aug 23
Registration of securities for employees
8:38pm
securities without stockholder approval as an inducement pursuant to Listing Rule 5635(c)(4) of the corporate governance rules of the Nasdaq Stock Market
8-K
EX-10.1
ej3o4l7c
23 Dec 22
Departure of Directors or Certain Officers
4:02pm
PRE 14A
henhmyi
17 Apr 20
Preliminary proxy
5:13pm
8-K
EX-99.1
ohqoacf3vrovhbhn
7 Nov 19
X4 Pharmaceuticals Reports Third Quarter 2019 Financial Results and Recent Business Highlights
7:10am
8-K/A
g8o4dq3l0ntl0dinzce
18 Oct 19
Departure of Directors or Certain Officers
4:31pm
8-K
EX-10.1
eucawn r0lp1qjyx55
19 Jun 19
Departure of Directors or Certain Officers
4:45pm